Explore By Subject Area   

Immuno-Oncology 360°

Date: Feb 10, 2026 - Feb 12, 2026

Location: Boston, MA

IO360° Strategic Advisors

IO360° Founding Advisors

Axel Hoos, MD, PhD
Former CEO, Scorpion Therapeutics

James Gulley, MD, PhD
Co-Director, Center for Immuno-Oncology, CCR & Clinical Director,
National Cancer Institute

Industry Advisors

Rick Aldridge, MBChB
Managing Director, Healthcare Investment Banking

William Ho, MBA
President & CEO, In8Bio

Andrew Baum, MD
Chief Strategy and Innovation Officer, Pfizer

Michael Kalos, PhD
Managing Director, Next Pillar Consulting

Daniel Chen, MD, PhD
Founder & CEO, Synthetic Design Lab

Theresa LaVallee, PhD
Chief Development Officer, Coherus BioSciences

Charles Drake, MD, PhD
VP, Immuno-Oncology, J&J Innovative Medicine

David Leung, MD, PhD
Head of Imaging, Daiichi Sankyo

Hanif Gabrani-Juma, BEng, MASc
Associate Director, Translational Medicine Strategy, Radiology Imaging & AI, Oncology R&D Cancer Biomarker Development, AstraZeneca

Jayant Narang, MD
Sr Medical Director, Clinical Oncology Imaging Lead, Preclinical and Translational Sciences, Takeda Pharmaceuticals

Diederik Grootendorst, PhD
Director, Global Oncology, Imaging

Rosanna Ricafort, MD
VP and Head, Hematology and Cellular Therapy Development, BMS

Gregory Frank, PhD
Global Scientific Partnering Strategy, Immuno-Oncology, GE Healthcare

Graig C Suvannavejh, PhD
Managing Director, Equity Research Biopharmaceuticals & Biotechnology, Mizuho Securities USA

Greg Goldmacher, MD, PhD, MBA
Associate VP, Clinical Research, Head, Clinical Imaging & Pathology,
Merck Research Labs

Alex Snyder, MD
Head, R&D, Generate Biomedicines

Asthika Goonewardene, MBA
Managing Director, Senior Biotech Analyst, Truist Securities

Leon “Jun” Tang, PhD
Founder, InScienceWeTrust BioAdvisory

Priti Hegde, PhD
SVP & Global Head of Research, Kite Pharma, a Gilead Company

Raluca Verona, PhD
Head, Oncology Precision Medicine Group, AbbVie

Catherine Hines, PhD
Executive Director and Head, Clinical Imaging, GSK

Wim Vos, PhD
CEO, Radiomics.bio

Sarah Warren, PhD
Sr Director, Corporate Development Lead, Cell Therapy Search and Evaluation, Kite Pharma, a Gilead Company

2025 Sponsors

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.